Health AI is designed to complement, and not replace, the relationship between patient and provider, Amazon says.
Bill would prohibit PBM compensation in Medicare Part D from being tied to the manufacturer’s list price of a drug.
Venture studio AION Labs' CEO Mati Gill says AION unites competing pharma companies in developing AI projects via a federated data platform, enabling pre-competitive collaboration while allowing each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results